Sérgio Lemos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sérgio Lemos has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Carla Lima
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
3 shared publications - Luisa Lemos Costa
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
3 shared publications - Ana Cunha Rodrigues
Centro Hospitalar Tondela Viseu, Portugal
2 shared publications - Andreia Silva
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
2 shared publications - Carolina Ferreira
Unidade Local de Saúde de Viseu Dão Lafões
2 shared publications Helena Viana
Nephrology Department, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal
2 shared publications
Latest Publications
- Open Access
- 12 February 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Case report: rivaroxaban related nephropathy
The characteristics of direct oral anticoagulants (DOACs) make them more appealing for prevention of thromboembolic events than vitamin K antagonists (VKA). Despite that, both classes have been a recognized as a cause of anticoagulant related nephropathy (ARN). Herein we describe a case of a 72-year-old man, with chronic kidney disease (CKD), medicated with rivaroxaban, who presented with acute kidney injury (AKI) and microscopic hematuria. The kidney biopsy revealed anticoagulant related-nephropathy. Rivaroxaban was suspended, the patient showed improvement of renal function and apixaban was prescribed. This case emphasizes the need for careful monitoring of serum creatinine when these drugs are prescribed, especially in high risk groups.
- 12 February 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Open AccessCase report: rivaroxaban related nephropathy
The characteristics of direct oral anticoagulants (DOACs) make them more appealing for prevention of thromboembolic events than vitamin K antagonists (VKA). Despite that, both classes have been a recognized as a cause of anticoagulant related nephropathy (ARN). Herein we describe a case of a 72-year-old man, with chronic kidney disease (CKD), medicated with rivaroxaban, who presented with acute kidney injury (AKI) and microscopic hematuria. The kidney biopsy revealed anticoagulant related-nephropathy. Rivaroxaban was suspended, the patient showed improvement of renal function and apixaban was prescribed. This case emphasizes the need for careful monitoring of serum creatinine when these drugs are prescribed, especially in high risk groups.
- Open Access
- 30 January 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Membranous nephropathy with collapse in a HIV negative patient; a case report with a 34-month follow-up
Membranous nephropathy (MN) is a common cause of nephrotic syndrome (NS) in nondiabetic adults. Collapsing nephropathy (CN) is a morphological pattern that is usually classified as a variant of focal segmental glomerulosclerosis (cFSGS). The simultaneous presence of both MN and CN is rare and their combination usually foresees an unfavorable outcome. Herein, we describe a case report of a patient with PLA2 R-associated MN with collapse, its treatment and clinical course.
- 30 January 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Open AccessMembranous nephropathy with collapse in a HIV negative patient; a case report with a 34-month follow-up
Membranous nephropathy (MN) is a common cause of nephrotic syndrome (NS) in nondiabetic adults. Collapsing nephropathy (CN) is a morphological pattern that is usually classified as a variant of focal segmental glomerulosclerosis (cFSGS). The simultaneous presence of both MN and CN is rare and their combination usually foresees an unfavorable outcome. Herein, we describe a case report of a patient with PLA2 R-associated MN with collapse, its treatment and clinical course.